Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine
Article in Best Practice & Research Clinical Endocrinology & Metabolism (May 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Best Practice & Research Clinical Endocrinology & Metabolism (May 2024)
Article in The Journal of Clinical Endocrinology & Metabolism (September 2023)